Cipla informs about press release

11 Aug 2015 Evaluate

Cipla has informed about a Press Release dated August 11, 2015 titled ‘Cipla announces a new respiratory inhaler: Synchrobreathe (SB), a state-of-the-art breath-actuated inhaler which will bring relief to millions of patients with Obstructive Airway Disease (OAD, asthma and COPD)’.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1328.25 15.40 (1.17%)
28-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.15
Dr. Reddys Lab 1224.30
Cipla 1328.25
Zydus Lifesciences 896.60
Lupin 2121.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×